Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients
1996

Detecting Breast Cancer Cells in Lymph Nodes

Sample size: 125 publication Evidence: moderate

Author Information

Author(s): A Schoenfeld, Y Luqmani, HD Sinnett, S Shousha, RC Coombes

Primary Institution: Charing Cross Hospital

Hypothesis

Can keratin 19 mRNA measurement improve the detection of micrometastases in lymph nodes of breast cancer patients?

Conclusion

The study found that keratin 19 mRNA measurement can detect micrometastases in lymph nodes of patients previously considered lymph node negative.

Supporting Evidence

  • 106 out of 530 lymph nodes showed detectable keratin 19 mRNA.
  • 30.6% of patients previously classified as lymph node negative were found to have micrometastases.
  • The presence of keratin 19 mRNA correlated with primary tumor size.

Takeaway

This study shows that a special test can find tiny cancer cells in lymph nodes that doctors thought were clear of cancer.

Methodology

The study used polymerase chain reaction (PCR) to measure keratin 19 mRNA in lymph nodes from breast cancer patients.

Limitations

The study may not apply to all types of breast cancer and the long-term prognostic significance of the findings is yet to be determined.

Participant Demographics

Patients undergoing axillary dissection for breast cancer, with a mean age of 52 years.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication